HNB
TRIB

Huntington National Bank’s Trinity Biotech TRIB Stock Holding History

Huntington National Bank’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-27
Closed -$12K – 2039
2021
Q2 		$12K Hold
27
– – ﹤0.01% 1420
2021
Q1 		$15K Buy
+27
New +$19.5K ﹤0.01% 1243
2020
Q1 		– Sell
-16
Closed -$2K – 1843
2019
Q4 		$2K Buy
+16
New +$2.28K ﹤0.01% 1593

Other funds holding TRIB

HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $868M AUM 32.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
WP
WealthSource Partners San Luis Obispo, California $1.54B AUM 16.68% 1-Year Est. Return
State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D Trenton, New Jersey $25.9B AUM 26.38% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Huntington National Bank's TRIB Position: Q3 2021 in Review

Huntington National Bank sold out of Trinity Biotech (TRIB) in Q3 2021, closing a stake of 27 shares — an estimated $12K sold.

Huntington National Bank first reported a position in TRIB in Q4 2019 and held it in 3 quarters. The position peaked at $15K in Q1 2021. 21 funds tracked by Wall St. Rank hold TRIB as of Q3 2021.

  • Huntington National Bank reported no remaining Trinity Biotech position as of Q3 2021 after selling out during the quarter.
  • Huntington National Bank sold 27 Trinity Biotech shares in Q3 2021, an estimated $12K.
  • Huntington National Bank first reported a position in Trinity Biotech in Q4 2019 and held it in 3 quarters.
  • Huntington National Bank's Trinity Biotech position peaked at $15K in Q1 2021.
  • 21 funds tracked by Wall St. Rank held Trinity Biotech as of Q3 2021.

Based on Huntington National Bank's 13F filing for Q3 2021, filed 28 Oct 2021.